Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2)

Bibliographic Details
Title: Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2)
Authors: Santoro, Nanette, Nappi, Rossella E., Neal-Perry, Genevieve, English, Marci, King, Deanna D., Yamaguchi, Yusuke, Ottery, Faith D.
Source: Menopause; April 2024, Vol. 31 Issue: 4 p247-257, 11p
Abstract: In this pooled analysis from the phase 3 SKYLIGHT 1 and 2 studies, none of the intrinsic and extrinsic factors identified in this study substantially reduced the response to fezolinetant at either the 30 or 45 mg doses.
Database: Supplemental Index
More Details
ISSN:10723714
15300374
DOI:10.1097/GME.0000000000002340
Published in:Menopause
Language:English